CCO Infectious Disease Podcast

Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment

Episode Summary

In this podcast episode, listen to expert faculty perspectives on HDV management, including their approach to complex clinical cases, staging liver disease, and screening for hepatocellular carcinoma.

Episode Notes

In this episode, Nancy Reau, MD, and Heiner Wedemeyer, MD, provide expert insight on HDV management, including:

• Use of noninvasive imaging or biopsy for staging liver disease
• Screening for hepatocellular carcinoma
• HBV treatment
• Role of comedications (eg, erythropoietin, eltrombopag)
• Approach to complex cases, such as patients with:
  • Significant fibrosis and low HDV RNA levels
  • Hepatitis delta antibody positivity, but HDV RNA negativity
  • HIV coinfection
  • Decompensated or recently decompensated cirrhosis

Faculty:

Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Heiner Wedemeyer, MD
Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology 
Hannover Medical School
Hannover, Germany

Link to full program: 
http://bit.ly/3yp1Lxf